Pontifax AgTech and Five Seasons Ventures have led a $10m series-A funding round for UK-based biotechnology company Tropic Biosciences.
DCI’s bolt-on of communications specialist Retis follows the acquisition of Lhexian last year
Exit delivers a 2x return on YFM Equity Partners' original £9m investment, made in September 2013
GP plans to hold a final close in H1 2019, sets target at €120m and hard-cap at €150m
Children's media production group will look to make acquisitions following the deal